Careers  |  Sign In  |  Register

FDA Prohibits Approval of Generic Versions of OxyContin

An article in The New York Times reports the FDA said “it would not approve generic versions of the powerful narcotic OxyContin, the painkiller that symbolized a decade-long epidemic of prescription drug abuse.” The original version of the drug “could be easily crushed, a step that released its entire narcotic payload at once rather than over time as intended” so in 2010, the drug manufacturer, Purdue Pharma, introduced a new formulation of the drug that was less prone to tampering. The FDA decision “came on the day when the patent for the original version of OxyContin was set to expire” and “is the first time that the agency has allowed a manufacturer to state that a narcotic drug has tamper-resistant properties.”

Read it in The New York Times.